NASDAQ^® NeuroInsights^® Neurotech Index

The Index includes companies researching, developing, manufacturing, and marketing pharmaceuticals, biologics, medical devices and diagnostics for the brain and nervous system. Index companies are defined by NeuroInsights as significantly involved in neurotechnology and must meet rigorous market criteria including a $200 million market capitalization and a three month average daily trading volume of 100,000 shares.

As of June 1, 2011 the index was up 70% compared to gains of 36% and 23% for the NASDAQ Biotech Index and the S&P 500.  A performance chart can be found here.

As of June 20, 2011 there are 23 component companies. Recent performance and news about each company can be found by clicking on the company name below.